Invirsa

A Phase 3 ready clinical-stage ophthalmology company pioneering the world's first DNA Repair Platform for ocular disease

Biotech & Life Sciences

Sector

Seed

Stage

Pharmaceutical Manufacturing

Model

01Company Overview

A Phase 3 ready clinical-stage ophthalmology company pioneering the world's first DNA Repair Platform for ocular disease.

02Backed By1 investor

03Similar Companies

S

SparingVision

Biotech & Life Sciences

→

AP

P

SB

H

04Startup DNA

8

signals

Sectors
Business Model
Technology